Company / Profit Margin
Axsome Therapeutics, Inc. Profit Margin History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-28.7%
FY2025
5-year range
-88.4% / -28.7%
FY2023-FY2025
Trend
+61.5%
vs FY2024
Sector context
#78 of 146
Health Care
What the data says
At -28.7%, Axsome Therapeutics, Inc.'s profit margin ranks #78 of 146 in the Health Care sector. Improved from -88.4% to -28.7% over the past 2 years.
Based on SEC 10-K filings.
-28.7% in FY2025.
Improved from -88.4% to -28.7% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#78 of 146 in Health CareTop 53% of 146This company -28.7% Sector average -796.3%
▼
+96.4% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 61.5% year-over-year.
- Currently 767.6pp above the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -28.7% | +61.5% |
| FY2024 | -74.5% | +15.8% |
| FY2023 | -88.4% | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026